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Abstract
Certain stimuli at the gut barrier may be necessary in early life to establish a proper balance
of immune tolerance. We evaluated a compromised barrier in juvenile mice in relation to
microbiota and local and systemic immunity. BALB/c mice were treated with a low dose of
dextran sulfate sodium (DSS) with or without ampicillin and lipopolysaccharide (LPS) to clar-
ify the importance of microbial antigens and interaction between microbial-associated pat-
terns and toll-like receptors. The barrier breach resulted in increased plasma LPS, which
was highest in mice treated simultaneously with ampicillin. Adding LPS in the food reduced
its levels in plasma. Regulatory T cells were acutely increased in mesenteric lymph nodes
(MLN) and spleen during DSS treatment regardless of simultaneous ampicillin treatment. In
contrast, NK T and NK cells decreased in MLN and in spleen. This acute DSS effect was
reflected in fold changes of haptoglobin and Il1a in colon, and this was also more pro-
nounced in mice simultaneously treated with ampicillin. On day 1 post-treatment, major
upregulations of Ifng, Foxp3, Il1b, Il2, and Il6 genes in colon were only observed in the mice
simultaneously treated with ampicillin. A two-fold upregulation of colonic Foxp3 and Il1a was
evident 25 days post-treatment. DSS skewed the microbiota in favor of Gram negative
phyla. Therefore, increased permeability induced tolerogenic immunity independent of
microbiota, and this was enhanced by LPS stimulation.
Introduction
As first proposed by Strachan in 1989 and since debated as the hygiene hypothesis [1], a suffi-
cient antigenic stimulus is likely necessary in early life to obtain protective regulatory immu-
nity against later life inflammatory diseases. This hypothesis has been further developed into
the “old friends” hypothesis [2] claiming that increasing incidences of inflammatory diseases
are more precisely due to an increasing lack of diversity in the gut microbiota over generations.
A relevant example of a widely discussed risk factor is caesarean section and the enhanced risk
of immune-mediated diseases. By this cleaner-than-intended delivery mode, the newborn may
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not readily be exposed to the maternal microbiota during vaginal birth resulting in delayed or
insufficient colonization [3] and reduced regulatory immunity [4].
The presence of mucosa-associated bacteria has been related to a healthy gut environment.
Bacteria express microbial-associated molecular patterns (MAMPs) which depending on age,
antigen type and -load, amount of immunosuppressive cytokines, as well as the presence of
antimicrobial peptides and host immune status, interact with host pattern-recognizing recep-
tors (PRRs), such as the important Toll-like receptors (TLRs) [5]. Akkermansia muciniphila
are mucus-decomposing Gram-negative bacteria of the Verrucomicrobia phylum. These bacte-
ria show reverse proportionality with inflammatory bowel disease (IBD) [6] and appendicitis
[7] in humans, they are reduced in abundance in children with autism [8], and they have been
linked to increased tolerance and decreased type 1 diabetes incidence in non-obese diabetic
mice [9]. Colonization of germ-free mice have shown that A. muciniphila prefer mucus-rich
locations such as the cecum, and are closely affiliated with the ileum and colon epithelium. In
comparison to Lactobacillus plantarum that upregulate host lipid metabolism, A. muciniphila
upregulates genes involved in antigen presentation, and, therefore, may play a significant role
as a commensal tolerance establisher [10,11]. Inoculation of gram-positive Clostridia species in
conventional mice in early life, mediates TGFβ production, increases Treg cells, and provide
protection from colitis later in life through TLR stimulation to [12]. Colonization with the
eight symbiotic strains of the altered Schaedler flora [13] expands the Treg cell population in
the colonic lamina propria, but not in the regional lymph nodes or systemically [14].
Dextran sulfate sodium (DSS) is a sulfated polysaccharide, which in solutions of 2–5% in
the drinking water, is used for induction of colitis in rodents. It has been suggested that DSS
with its effects on mucus layer integrity on gene level [15] and on ex vivo penetrability [16]
induces mucosal permeability and microbial translocation that in fact precede inflammation
[17]. DSS exposure induces severe colonic injury with systemic morbidity in mice deficient of
MyD88, an essential downstream adaptor molecule for most MAMPs, but this was completely
prevented by antibiotics followed by oral administration of the Gram-negative TLR4 ligand
lipopolysaccharide (LPS), and the Gram-positive TLR2 ligand lipoteichoic acid [18]. In this
study, IL-6 and TNF-α were upregulated in DSS-treated wild-type mice, while they were
downregulated in DSS-treated MyD88 deficient mice [18]. The compromised mucosal integ-
rity caused by a low, non-inflammatory dose of DSS may, therefore, if given shortly in early
life, allow an increased mucosal immune cell-MAMP interaction, and thereby mimic the
mucin degrading effects of A. muciniphila.
We evaluated the effect of a low-dose DSS-induced compromised intestinal barrier on
immune cells, intestinal mRNA transcripts and gut microbiota (GM) in juvenile mice. We
hypothesized that this DSS treatment would compromise the mucosal barrier sufficiently for
the gut bacterial antigens to induce a regulatory tolerant immune response even without clini-
cal inflammation. Five weeks old BALB/c mice were treated for seven days with 1.5% DSS,
alone (full microbiota) or in combination with ampicillin (suppressed microbiota) to investi-
gate the necessity of bacterial stimuli during the barrier breach, and in combination with LPS
to specify the need for TLR4 signaling.
Materials and methods
The study was conducted in agreement with Directive 2010/63/EU of the European Parliament
and of the Council of 22 September 2010 on the protection of mice used for scientific purposes,
and the Danish Animal Experimentation Act (LBK 474 15/05/2014). The study was approved
by The Animal Experiments Inspectorate under The Ministry of Environment and Food of
Denmark (License: 2007-561-1434 C3).
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Mice and experimental design
120 female BALB/cAnNBomTac mice, three weeks old at arrival, were randomly allocated to
20 standard cages (type 1290, Techniplast, Italy) with six mice in each cage. The 20 cages were
randomized into four groups with five cages in each. Mice were purchased with a health report
according to Taconic’s routine health monitoring program. In the unit, sentinel mice were
serologically tested for mouse hepatitis virus, reovirus type 3, Theiler’s virus (GDVII), Sendai
virus, minute virus of mice, mouse parvovirus, rotavirus (EDIM) and Clostridium piliforme
(Biodoc Diagnostics, Hannover Germany). Fecal samples from cages were tested in-house for
endoparasites (Fecalyzer, Kruuse A/S, Marbjerg, Denmark). Full microbiota 16S sequencing
was done in-house on samples from a high number of mice from the studies, as described
below. None of the assays revealed any agents to be reported according to FELASA guidelines
for health monitoring.
From arrival to treatment in week five, all mice were fed a standard Altromin 1324 diet
(Altromin, Germany). During week five, one group was treated with DSS in the drinking
water (1.5%, dextran sulfate sodium, cat. no. 160110, lot no. M2709, MW = 36000–50000, MP
Biomedicals, USA). Two groups received ampicillin in the drinking water from arrival (1 g/L
Ampivet Vet, 250 mg/ml, Boehringer Ingelheim, Germany) and were then during week five
either simultaneously treated with DSS, or with DSS and a diet containing added lipopolysac-
charide (Rodent diet D12070602, 40.8 mg/kg LPS, Brogaarden, Denmark). The other treat-
ment groups received a corresponding control diet (Rodent diet D12450J). After one week of
treatment all groups received standard diet and tap water (S2 Fig). Housing conditions were: a
7 a.m.–7 p.m. light/dark cycle, 440 lx light intensity, relative humidity 55% +/−10%, and a 20–
24˚C temperature. The mice were provided with Aspen bedding (Tapvei, Estonia) with supple-
ment of Enviro-dri and Alpha-Nest nesting material (SSP, USA), Shepherd’s Shacks (regular,
SSP, USA), and Aspen chew blocks (Tapvei, Estonia).
The mice were killed on days 3 and 5 during treatment and on days 1, 7, and 25 post-treat-
ment. From these time points samples of blood, feces, liver, ileum and colon were taken. On
day 3 during treatment and on day 25 post-treatment, the spleen and mesenteric lymph nodes
were sampled. For histology, samples of ileum and colon were preserved on day 3 during treat-
ment and on day 1 and 25 post-treatment. Samples from day 3 of treatment and from days 1
and 25 post-treatment were analyzed.
The mice were sedated with a 1:1 Hypnorm/Midazolam mixture (0.315 mg/ml fentanyl and
10 mg/ml fluanisone (Hypnorm, VetPharma, Denmark) and 5 mg/ml midazolam (Roche,
Denmark)), blood was obtained from the orbital sinus, and the mice were killed by cervical
dislocation.
Gene expression
Ileum and colon samples were placed in RNAlater upon removal (Qiagen) and kept at
-20˚C until processing. The samples were transferred to gentleMACS™ M tubes (MACS,
Miltenyi Biotec, Lund, Sweden) containing QIAzol (Qiagen, Ballerup, Denmark) and
homogenized using the gentleMACS™ Dissociator (MACS, Miltenyi Biotec). Total RNA
was extracted with chloroform (Merck, VWR, Herlev, Denmark) and ethanol (Kementyl,
VWR), and subsequently isolated using the RNeasy Lipid kit (Qiagen) including on-column
digestion of genomic DNA using the RNase-Free DNase set (Qiagen) according to manu-
facturer’s protocol. Total RNA concentration and purity were measured using a NanoDrop
ND-1000 spectrophotometer (Saveen and Werner AB, Sweden), and the RNA integrity
was assessed using the Agilent Bioanalyzer 2100 and RNA 6000 Nano Kit (Agilent
Technologies).
Reduced mucosal integrity in early life
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An RNA Integrity Number (RIN) from 1–10 was assigned to each total RNA sample by the
Agilent Bioanalyzer, with 10 being non-degraded RNA. RINs for ileum samples were between
7.8–10.0 (av. 9.3) and 6.6–9.8 (av. 8.9) for colon samples (S3 Table). First-strand cDNA synthe-
sis was performed with 500 ng total RNA per sample (water for non-template-controls/non-
RT-controls) using the QuantiTect Reverse Transcription Kit (Qiagen) according to manufac-
turer’s protocol. For assay validation, two cDNA synthesis reactions were prepared per sample.
Prior to preamplification, the cDNA was diluted 1:6 in low EDTA TE-buffer (VWR—Bie &
Berntsen, Herlev). Preamplification was performed using TaqMan PreAmp Master Mix
(Applied Biosystems). Stocks of 200 nM primer mix were prepared combining equal concen-
trations of all primers used in the present study. TaqMan PreAmp Master Mix (5 μl) was
mixed with 2.5 μl 200 nM stock primer mix and 2.5 μl diluted cDNA, and incubated at 95˚C
for 10 minutes followed by 16 cycles of 95˚C for 15 sec. and 60˚C for 4 min. Before qPCR, pre-
amplified cDNA was diluted at least 1:4 in low EDTA TE-buffer (VWR—Bie & Berntsen).
Primers were designed using Primer3 (http://frodo.wi.mit.edu/), synthesized at Sigma-Aldrich
(Denmark), as previously described [19] (primers, gene names and abbreviations are presented
in S4 Table). Amplification efficiencies, dynamic range, and specificity were estimated based
on four separate dilution series of pooled cDNA and melting curve profiles. Quantitative PCR
was performed in 48.48 Dynamic Array Integrated Fluidic Circuits (Fluidigm, CA, USA.),
combining 48 samples with 48 primer sets for 2304 simultaneous qPCR reactions as previously
described [20]. Non-template controls (NTC) were included to monitor any potential prob-
lems with non-specific amplification or sample contaminations. Non-reverse transcriptase
controls were included to assess potential genomic DNA contamination.
Expression data (Cq values) were acquired using the Fluidigm Real-Time PCR Analysis
software 3.0.2 (Fluidigm) and exported to GenEx (MultiD, Go¨teborg) for data pre-processing
including correction for PCR efficiency for each primer assay individually, normalizing to
highly stable reference genes, and using technical repeats of cDNA. For the ileum samples,
ribosomal protein L13a (Rpl13a), beta-2 microglobulin (B2m) and beta-actin (Actb) were
identified as the most stable expressed reference genes out of 8 candidates using GeNorm [21]
and NormFinder [22]. This also applied to the colon samples, with addition of the reference
gene beta-glucuronidase (Gusb). For each primer assay, the mean relative expression level was
set to 1 in the group with the lowest level of expression, and all other groups were adjusted
accordingly during log-transformation (log2) to linear scale.
Cell isolation and flow cytometry
The number of Treg and NK/NK T cells in the spleen and mesenteric lymph nodes (MLN)
were counted for assessment of general and local immune cell recruitment. The tissues were
harvested and immediately placed in cold PBS on ice. Cells were isolated from spleen and
MLN collected immediately upon euthanasia by aseptically squeezing the fresh organs in PBS
between two microscope slides and subsequently passing the suspension through a 70 μm cell
strainer. Flow cytometric analyzes of NK, NK T, and FoxP3+ Treg cells were done as previously
described [9]. All antibodies were purchased from eBiosciences. The analyses were performed
using an Accuri C6 flow cytometer (Accuri Cytometers Inc, Ann Arbor, MI).
LPS
LPS content was measured with a fluorescence excitation/emission ELISA system (Pyrogene
Recombinant Factor C Endotoxin Detection Assay, 50-658U, Lonza, Germany) in plasma
diluted 1:1000 with MgCl2 (10mMol, S50-641, Lonza, Switzerland), established by the prod-
uct inhibition test according to manufacturer’s protocol. The diluted samples were heat-
Reduced mucosal integrity in early life
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inactivated in a 70˚C water bath for 10 minutes before proceeding, as recommended by the
manufacturer. The fluorescence is proportional to the endotoxin concentration in a double
log scale and is linear in the 0.005 to 5.0 EU/ml range.
Histology
Ileum and colon samples were preserved in either formalin or Carnoy’s fixative for 24 hours
and kept in ethanol until they were embedded in paraffin, sliced and HE and Alcian-Blue/PAS
dyed.
Body weight, food and water consumption
Minimum once a week the weights of mice, food, and water bottles were noted and accumu-
lated body weights along with food and water consumption were calculated.
Bacterial DNA
Fecal pellets were collected upon handling into an autoclaved microtube, placed on wet ice
and stored at -80˚C. Bacterial DNA was extracted with QIAamp DNA Stool Mini Kit 51504
(Qiagen). Quality and quantity of DNA were spectrophotometrically evaluated (NanoDrop
1000, Thermo Scientific, USA) and stored at -80˚C. Samples were cleaned (PowerClean1 Pro
DNA Clean-Up Kit, Mobio Laboratories, USA), and spermine was added to prevent DSS
inhibiting the polymerase (unpublished manuscript).
High throughput sequencing
The fecal microbiota of 45 mice was determined using tag-encoded 16S rRNA gene MiSeq-
based (Illumina, CA, USA) high throughput sequencing. Cellular DNA extraction, DNA
storage condition, and sequencing library preparation steps were conducted as previously
described [23]. The raw dataset containing pair-ended reads with corresponding quality scores
was merged and trimmed using settings as previously mentioned. Quantitative Insight Into
Microbial Ecology (QIIME) open source software package [24] (1.7.0 and 1.8.0) was used for
subsequent analysis steps. Purging the dataset from chimeric reads and constructing de novo
Operational Taxonomic Units (OTU) was conducted using the UPARSE pipeline [25]. The
green genes (13.8) 16S rRNA gene collection was used as a reference database [26].
Principal coordinate analysis (PCoA) plots were generated with the Jackknifed Beta Diver-
sity workflow based on 10 distance metrics calculated using 10 subsampled OTU tables. The
number of sequences taken for each jackknifed subset was set to 85% of the sequence number
within the most indigent sample. Analysis of similarities (ANOSIM) was used to evaluate
group differences using weighted and unweighted UniFrac [27] distance metrics that were
generated based on rarefied (10,000 reads/sample) OTU tables. The relative distribution of the
genera registered was calculated based on subsampled OTU tables (summarized to the genus
level).
Alpha diversity measures expressed with an observed species (sequence similarity 97%
OTUs) value were computed for rarefied OTU tables (10,000 reads/sample) using the alpha
rarefaction workflow. Differences in alpha diversity were determined using a t-test-based
approach employing the non-parametric (Monte Carlo) method (999 permutations) imple-
mented in the compare alpha diversity workflow.
ANOVA was used to determine qualitative quantitative (relative abundance) association of
OTUs with the given group. These were calculated based on 1000 subsampled OTU tables rar-
efied to an equal number of reads (10,000 per sample) and summarized to the genus level.
Reduced mucosal integrity in early life
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Both the p-value and the conservative FDR-corrected p-value for multiple comparisons are
reported.
General statistics
qPCR: Fold change was calculated based on relative Cq values, and the criteria of <-2 or >2
were applied. Differentially expressed mRNA transcripts were tested with multiple t-tests
with Benjamini-Hochberg correction. Flow cytometry and LPS: Normalized data was tested
with ANOVA or unpaired two-tailed t-test. Correlations: Permutation based method was
used to initially calculate r and p between relative counts of operational taxonomic units and
immunological data, and Pearson correlation in Graphpad Prism 7.02 was used for graphical
presentation.
Results
LPS leak to the plasma was dependent on antigen presence
DSS treatment increased the amount of LPS in plasma during treatment, demonstrating a
breach in the intestinal barrier. This was also evident in a bacterially suppressed state, which as
hypothesized shows a direct effect of DSS on the gut. Addition of LPS in the diet during DSS
treatment did not increase plasma LPS further (Fig 1). In fact, there seemed to be a protective
effect of TLR4 signaling on the gut barrier, as plasma LPS was improved in mice receiving die-
tary LPS compared to the mice only treated with ampicillin. The compromised barrier resulted
in increased plasma LPS in all treatment groups compared to the control group. However, in
all mice, except for those receiving both DSS and ampicillin, the levels were decreased when
the treatment was terminated (Fig 1).
Acute increase in Treg cells and late decrease in NK and NK T cells
On day 3 of treatment, MLN of all treatment groups contained more activated T helper cells
compared to the control group. This was not evident in the spleen (Fig 2A).
The fractions of CD4+FoxP3+CD25+ Treg cells were significantly increased in both MLN
and spleen in DSS-treated groups on day 3; even if treated simultaneously with ampicillin
which indicates that microbes were not responsible for this effect (Fig 2B). 25 days post-
treatment this effect had vanished. In contrast, there was a late effect on NK T cells and
NK cells which were significantly decreased on day 25 post-treatment in all treatment
groups, most significantly for mice treated with DSS, ampicillin and LPS in combination
(Fig 2C+2D).
Microbiota suppression increased the compromising effect on the barrier
The mRNA transcripts of 35 genes (S4 Table) were evaluated and considered relevant when at
least 2-fold up or downregulated in treated mice compared to control mice (Table 1 and S1
Table). The largest fold regulations were observed on day 1 post-treatment, when Hp and Il1a
were upregulated in the colon of DSS mice with a larger fold change in mice simultaneously
treated with ampicillin. A 7-9-fold upregulation of Ifng and 2-8-fold upregulations of Foxp3,
Il1b, Il2, and Il6 in colon were only observed in mice simultaneously treated with ampicillin,
suggesting an increased barrier-compromising effect of microbiota suppression. Interestingly,
Muc1 in colon was upregulated in DSS mice simultaneously treated with ampicillin, but not
when supplemented with LPS. On day 3 of treatment a 2-fold upregulation of Il2 together
with a 2-3-fold downregulation in Il10 and Muc2 were observed in the colon of DSS mice
Reduced mucosal integrity in early life
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simultaneously treated with ampicillin. On day 25 after treatment there was a small late effect
in DSS mice simultaneously treated with ampicillin with a 2-fold upregulation of Foxp3 and
Il1a in colon.
DSS treatment decreased gut microbiota diversity with a skewing
towards Gram-negative phyla
There were clear time point differences and development in the bacterial composition within
each treatment group (S1 Fig). Ampicillin-treated mice on days 3 and 1 post-treatment were
excluded due to the low DNA concentration in the isolates, confirming suppression of bacte-
ria. Due to the absence of qualitative or quantitative differences in bacterial composition, these
groups were combined as one on day 25 post-treatment. On days 3 and 1 post-treatment the
species diversity was significantly reduced in DSS-treated mice compared to control mice
(p<0.01). This discrepancy was lost on day 25 post-treatment, when only the ampicillin-
treated groups had significantly reduced diversity compared to the control group. Mice only
treated with DSS regained their diversity (alpha diversity measures expressed with observed
species index).
Fig 1. Plasma lipopolysaccharides. Lipopolysaccharides measured by ELISA in plasma of mice during, as well as 1
and 25 days post-treatment with 1.5% dextran sulfate sodium (DSS), 1g/L ampicillin and/or diet containing 40.8 mg/kg
lipopolysaccharides (LPS). Box and whisker plots, + shows mean; whiskers: min.-max., n = 5–6 per group (p.t. = post-
treatment, p-values: ** = <0.01; *** = p<0.001, compared to control group. All controls from day 3 were only 50%
above detection limit of the assay).
https://doi.org/10.1371/journal.pone.0176662.g001
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Overall, in an overview of the 20 most abundant species at each time point, the DSS treat-
ment tended to skew the bacterial composition in favor of Gram-negative phyla (Figs 3–6 and
S2 Table). DSS treatment significantly decreased the family of Rikenellaceae (control = 18%,
DSS = 2%), and increased the Gram-negative Bacteroides genus (control = 9%, DSS = 58%) on
day 3 of treatment, both belonging to the Bacteriodetes phylum. In turn, DSS treatment
decreased the Gram-positive Firmicutes genus Candidatus Arthromitus also known as seg-
mented filamentous bacteria (SFB) (control = 0.2%, DSS = 0.004%), and the Firmicutes order
of Clostridiales (control = 39%, DSS = 5%) (Fig 3). On day 25 post-treatment, Bacteroides spp.
were still significantly increased in the DSS-treated mice (Fig 5), and a member of the Bacteroi-
dales order, S24-7, decreased as described for day 3 of treatment and day 1 post-treatment (Fig
4). For most other significantly different bacteria, the DSS mice on day 25 post-treatment (Fig
5) resembled the control animals. In contrast, Rikenellaceae and Firmicutes families were
together with several Bacteriodetes families still reduced in the ampicillin-treated mice, com-
pared to control and DSS mice (Fig 6).
Fig 2. Immune cell flow cytometry. Flow cytometric analysis of cells isolated from mesenteric lymph nodes (MLN) and spleen in mice during and
25 days post-treatment with 1.5% dextran sulfate sodium (DSS), 1g/L ampicillin and/or diet containing 40.8 mg/kg lipopolysaccharides (LPS).
Percentages of CD4+CD25+ activated T helper cells present among all lymphocytes (A), FoxP3+ Treg cells among CD4+ T cells (B), NKT+ among all T
cells (C) and NK cells among all lymphocytes (D) are shown. Box and whisker plots, + shows mean; whiskers: min.-max., n = 5–6 per group as shown
by dots (p-values: * = p<0.05; ** = <0.01; *** = p<0.001, no line: compared to control group).
https://doi.org/10.1371/journal.pone.0176662.g002
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OTUs correlated with immunological changes
On day 3 of DSS-treatment Bacteriodetes spp. increased and this correlated with increase of
Treg in mesenteric lymph nodes (MLN) (Fig 7A), and with upregulation in RELMβ transcripts
(Fig 7B+7C). Interestingly, a lower amount of the Firmicutes family Erysipelotrichaceae corre-
lated with lower amounts of IL-23 and IL-1α transcripts in control mice, compared to
increased amounts of Erysipelotrichaceae and IL-23 and IL-1α in DSS-treated mice (Fig 7D).
Similarly, on day 1 following DSS treatment, MUC1 expression and relative counts of Parabac-
teroides spp. belonging to the Bacteriodetes genus correlated reversely in DSS treated mice
compared to control (Fig 7E+7F). Odoribacter and Prevotella spp. correlated negatively to
FoxP3 and IL18 on day 25 after DSS treatment, and Cyanobacteria was negatively correlated
Table 1. Fold change <-2 or >2 of mRNA transcripts.
COLON* Day 3 of treatment** Day 1 pt Day 25 pt
DSSa DSS+Ampb DSS+Amp+LPSc DSS DSS+Amp DSS+Amp+LPS DSS DSS+Amp DSS+Amp+LPS
Cxcl9 4.10 7.17
Defa 2.09 3.99
Foxp3 2.89 2.45 2.14
Hp 12.13 5.34 4.62 3.92 5.83 4.30
Ifng (1) 7.88 8.32
Ifng (2) 9.03 9.44
Il23 3.25
Il10 -3.73 -2.65
Il1a 2.02 4.57 3.31 2.09
Il1b 2.89 3.55
Il2 2.35 2.19 5.03 2.75
Il6 7.97 3.61 15.91 8.32
Muc1 (1) 2.86 3.20 2.11 2.93 2.00
Muc1 (2) 2.53 2.07
Muc2 (1) -4.63 -2.07 -2.09
Muc2 (2) -2.59
ILEUM Day 3 of treatment Day 1 pt Day 25 pt
DSS DSS+Amp DSS+Amp+LPS DSS DSS+Amp DSS+Amp+LPS DSS DSS+Amp DSS+Amp+LPS
Cxcl10 -3.10 -2.37
Cxcl9 -3.93 -3.35
Ifng (1) -3.54 -3.97 -5.84 -12.11 -8.58 -4.17
Ifng (2) -6.25 -6.52 -3.90
Il10 -2.17 -2.41 -3.31 -4.24 -2.96
Il18 2.15 2.02
Il6 2.72
Retnlb -4.26 -39.78 -11.03 -12.17 -2.58
mRNA from mouse ileum and colon during, as well as 1 and 25 days post treatment with 1.5% dextran sulfate sodium (DSS), 1g/L ampicillin and/or diet
containing 40.8 mg/kg lipopolysaccharides (LPS). Control = 1. Bold: statistically significant (t-test with FDR). Light to dark blue: decreasing fold change <-2;
Pink to red: increasing fold change >2.
*See S4 for gene names.
**See S2 Fig for study design.
aDSS; dextran sulfate sodium,
bAmp; ampicillin,
cLPS; lipopolysaccharide.
https://doi.org/10.1371/journal.pone.0176662.t001
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to TGFβ (Fig 7G–7I). Interestingly, for the two groups treated with DSS and ampicillin (with
or without LPS), there was a negative correlation between Treg cells and relative counts of the
Lachnospiraceae family 25 days post-treatment (Fig 7J+7K).
No clinical effect of low-dose DSS in the absence of microbiota
suppression
Clinically, the DSS-only treated mice were statistically indistinguishable from the control
mice, with only small perturbations in food and water intake mildly resembling the pattern of
the ampicillin-treated groups immediately following treatment cessation (Figure D in S1 File).
The ampicillin-treated mice showed small transient weight loss, decreased food intake and a
significant increase in water intake compared to control mice (Figures B+C+D in S1 File). In
turn, the mice were monitored on a daily basis for clinical signs of colitis, and the ampicillin-
treated mice were examined on day 1 post-treatment, as a few mice were observed with bloody
Fig 3. Distribution of the 20 most abundant phyla on day 3 of treatment. Overview of relative phylogenetic distribution and details of variation
down to genus level of gut microbiota of untreated control mice and mice during treatment with 1.5% dextran sulfate sodium (DSS). There were too few
reads from DSS+Ampicillin and DSS+Ampicillin+LPS treated mice on day 3 and day 1 post-treatment. Verrucomicrobia amount on day 3 and day 1
post-treatment is for one mouse only. See S2 Table for analysis of variance.
https://doi.org/10.1371/journal.pone.0176662.g003
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stools from day five of treatment. When the treatment ended, all mice from these groups
returned to normal, showing no signs of colitis. Water intake differed slightly between the
groups (Figures B+D in S1 File). This led to slight differences in DSS intake (Figure A in S1
File) ranging from 14.1 to 21.3 mg DSS per gram body weight in the individual mice, but it has
previously been shown that DSS load only acts in a straight dose-dependent manner in a criti-
cal load above 30 mg per gram body weight [28]. Histological sections showed no apparent
aberrations on any day of sampling.
Discussion
In this study, young mice were treated with a low dose of DSS for seven days. Mice treated
with DSS alone did not exhibit any clinical signs and were similar to control mice in weight
and food and water intake.
Some mice were simultaneously treated with ampicillin, and others were, in addition to
DSS, treated with LPS in the diet. The ampicillin-treated mice with no LPS added were found
Fig 4. Distribution of the 20 most abundant phyla on day 1 post-treatment. Overview of relative phylogenetic distribution and details of variation
down to genus level of gut microbiota of untreated control mice and mice during treatment with 1.5% dextran sulfate sodium (DSS). There were too few
reads from DSS+Ampicillin and DSS+Ampicillin+LPS mice on day 3 and day 1 post-treatment. Verrucomicrobia amount on day 3 and day 1 post-
treatment is for one mouse only. See S2 Table for analysis of variance.
https://doi.org/10.1371/journal.pone.0176662.g004
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to continuously leak more LPS to the plasma, which may suggest that TLR4 signaling actually
protects the gut barrier and impedes LPS leakage from the gut. It could, therefore, be of inter-
est to study the impact of this early life low-dose DSS treatment with and without dietary LPS
in TLR4 deficient mice. In turn, Muc1 in colon was only significantly upregulated in DSS mice
simultaneously treated with ampicillin on day 1 post-treatment, whereas DSS treatment alone
or supplementation with LPS did not produce a Muc1 upregulation. The upregulation could
be interpreted as a compensatory mechanism in response to DSS removal of mucus, as previ-
ously shown [29], and hence, LPS or full GM protected from removal of mucus, thereby sup-
porting a healthy barrier. This is in line with the study in which LPS and lipoteichoic acid
alone protected against inflammation [18]. In our study, the amount of mRNA coding for the
LPS receptor gene Tlr4 (and of the Tlr1 gene) was significantly regulated, but below our fold
criterion, hence the biological relevance of this result was questioned and not included.
Treg cells were increased on day 3 of treatment in MLN and spleen of all DSS-treated
groups, and as Treg cells and Foxp3 mRNA transcripts were also increased in ampicillin-treated
mice, these effects seemed to be independent of GM, and hence, point at a direct local and
Fig 5. Distribution of the 20 most abundant phyla on day 25 post-treatment (Control and DSS). Overview of relative phylogenetic distribution
and details of variation down to genus level of gut microbiota of untreated control mice compared to mice 25 days post-treatment with 1.5% dextran
sulfate sodium (DSS). See S2 Table for analysis of variance.
https://doi.org/10.1371/journal.pone.0176662.g005
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systemic effect of this barrier compromise. Our study further showed that DSS treatment pro-
motes Gram-negative phyla, especially Bacteriodetes, which correlated with Treg cells in the
MLN and mRNA transcripts of the barrier-related Retnlb (Relmβ) on day 3 of DSS treatment.
Interestingly, Parabacteroides spp. were inversely correlated to colonic MUC1 expression in
control and DSS treated mice on day 1 following DSS treatment, with a positive correlation in
DSS treated mice. In turn, 25 days after DSS treatment Odoribacter spp. and Prevotella spp.
were negatively associated with FoxP3 and IL-18 expression. The Bacteriodetes family has pre-
viously been linked to DSS treatment [30,31], and thus it is not unrealistic that DSS increases
the chance of LPS/TLR-receptor interaction leading to tolerogenic cell responses.
In our study, an acute effect of DSS was reflected in fold changes of Hp and Il1a in colon on
day 3 of treatment, and this effect was more pronounced in mice also treated with ampicillin.
On day 1 post-treatment, major upregulation of Ifng, Foxp3, Il1b, Il2, and Il6 in colon was only
observed in bacterially depleted mice in which LPS leakage was also highest. Interestingly, a
2-fold upregulation of Foxp3 and Il1a in colon was evident later on, which was seemingly a
local effect not apparent at the more systemic cellular level. Others have also reported a classi-
cal Th1 response in BALB/c mice with increasing upregulation in Il12, Ifng, Il1, and Tnfα as
Fig 6. Distribution of the 20 most abundant phyla on day 25 post-treatment (DSS+Ampicillin (+LPS) groups combined). Overview of relative
phylogenetic distribution and details of variation down to genus level of gut microbiota of untreated control mice compared to mice 25 days post-
treatment with 1.5% dextran sulfate sodium (DSS), 1g/L ampicillin (Amp) and/or diet containing 40.8 mg/kg lipopolysaccharides (LPS). There were too
few reads from DSS+Amp and DSS+Amp+LPS mice on day 3 and day 1 post-treatment. As no qualitative or quantitative differences in bacterial
composition were found between DSS+Amp mice and DSS+Amp+LPS on day 25 post-treatment, these groups were combined for this time point. See
Fig 5 for control group and DSS group. See S2 Table for analysis of variance.
https://doi.org/10.1371/journal.pone.0176662.g006
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Fig 7. Correlations of relative counts of some operational taxonomic units and parameters. OTUs from gut microbiota and immunological
parameters of untreated control mice and mice treated with 1.5% dextran sulfate sodium (DSS) alone or in combination with ampicillin (Amp) and
lipopolysaccharides (LPS). The permutation based method was used to calculate r and p. Depicted p-values are FDR corrected. A-D: Day 3 of
treatment. A. FoxP3+CD4+; p = 0.0485, r = 0.88, CD25+CD4+; p = 0.0087, r = 0.93. B. RELMβ (primer 1); p = 0.0022, r = 0.97, RELMβ (primer 2);
p = 0.00009, r = 0.97. C. RELMβ (primer 1); p = 0.0131, r = 0.91, RELMβ (primer 2); p = 0.0100, r = 0.92. D. IL-23; p = 0.0391, r = 0.92, IL1α;
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dosage of DSS increased (2.5, 5 and 7.5%) [32], as well as slight increases of IL-6, IL-17, and
IL-4 [33] were observed.
The bacterial presence in the gut after antibiotic treatment must logically depend on treat-
ment regimen and recolonization time, in combination with handling and housing status. In
this study, the mice were treated with ampicillin from arrival at three weeks until six weeks of
age (with simultaneous treatment with DSS and LPS during week five), and then evaluated 25
days post-treatment (S2 Fig). Samples were collected on day three in week five, and day one in
week six, and it was not possible to yield enough reads due to the very low DNA concentration
of the isolates, at least confirming successful depletion at these time points. The results of oth-
ers using the same dose of ampicillin range from elimination of all aerobic bacteria [34],
increase in Streptococcaceae and Lactobacillaceae [35], and a general decrease of all bacteria
[18], to extended effects in combination with other antibiotics (see [36]). Consequently, the
GM was most likely only heavily suppressed, despite the very low DNA concentration in the
fecal samples of the ampicillin-treated mice. One potential follow-up study would, therefore,
be to treat germ-free mice with DSS and LPS, which in relation to the present study would
have the advantage that the mice would be fully devoid of bacteria. The advantage of the pres-
ent approach using ampicillin is that all mice have experienced similar neonatal priming with
bacteria at birth, and the microbiota-suppressed group is only suppressed during the experi-
mental period. A study with germ-free mice adds up both effects of neonatal priming and cur-
rent microbial stimulation [37]. Furthermore, the control group would either have to be ex-
germ-free inoculated mice, which may not necessarily establish a full GM [38], or conventional
mice subjected to bacterial priming at birth. DSS lowered the microbial diversity during and
immediately following treatment, but this was regained later on, whereas decreased diversity
was still present in ampicillin-treated mice. The early effect of DSS on Treg cells and the late
effect on NK/NK T cells were also present in ampicillin-treated mice suggesting that it is the
effect on the barrier rather than the effect on the microbes that is of importance. It is very likely
that increased contact with dietary antigens during DSS treatment promoted the oral tolerance
independently of the microbial antigens present.
Five weeks of age may be too late to permanently affect immune parameters, and studies
focusing on the pre-weaning period or pre-birth conditions have successfully been able to
modulate immune parameters showing a long-term effect, for instance by maternal diet [39]
and GM colonization of GF mice [38], on Treg and NK T cell populations. However, studies of
probiotic intervention at later ages also reported successful outcomes [40,41], and the immune
system of rodents is not fully developed until sexual maturity [42]. The question remains if
and when an early life gut barrier breach is positively associated with health. Studies of obesity
and type 2 diabetes point to a negative systemic effect of what is called a “leaky gut” where a
high level of LPS in the blood leads to constant low-grade inflammation [43]. Naturally, it is
necessary to distinguish between biological leakiness early and late in life, and the adult
homeostatic condition in between. Perhaps immune system priming is especially important
during exposed stages of life, such as during the early life immune system immaturity, when
education is essential for further development, or during the old life immune system exhaus-
tion with constant need for “nudging”.
Our data show similarity to DSS colitis induction in the acute stage with a low inflamma-
tory response and a transient Treg increase. The decreased levels of NK and NK T cells later in
p = 0.0012, r = 0.97. E+F: Day 1 post-treatment. E: p = 0.0046, r = 0.97. F: p = 0.0105, r = 0.96. G-K: Day 25 post-treatment. G. p = 0.0010, r = -0.9914.
H. p = 0.0124, r = -0.9876. I. TGFβ (primer 1); p = 0.0244, r = -0.9251, TGFβ (primer 1); p = 0.0209, r = -0.9325. J. FoxP3+CD4+; p = 0.0208, r =
-0.8799, CD25+CD4+; p = 0.0162, r = -0.8942. K. FoxP3+CD4+; p = 0.0154, r = -0.9449, CD25+CD4+; p = 0.0079, r = -0.9648.
https://doi.org/10.1371/journal.pone.0176662.g007
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life may indicate relocation to tissues or a sign of regulatory change. In fact, it has been estab-
lished that an important interplay exists between Treg and NK T cells in regulatory immunity,
as NK T cells are able to modulate Treg function by IL-2 secretion, which was also found upre-
gulated in the present study, and inversely, NK T cell proliferation, cytokine expression and
cytotoxic activity can be inhibited by Treg cells [44]. The innate NK cells are also highly interre-
lated with Treg cells, in disease states and during normal homeostasis. During pregnancy, these
two cell types seem to work together to create tolerance, and in cancer a high number of Treg
cells, presumably suppressing NK cells, often correlates with poor disease outcome [45].
Hence, the increase in Treg cells during early DSS treatment is possibly a factor in the later
observed decrease in NK and NK T cells. NK T cells are regulated by the intestinal environ-
ment [46], and they have been reported increased in the colon of GF mice from weaning and
through life compared to specific pathogen-free mice, leading to increased severity of oxazo-
lone-induced colitis, which was reversed if neonatal GF mice were colonized with a conven-
tional GM [47].
We hypothesized that a short low-dose DSS treatment in five weeks old BALB/c mice
would compromise the mucosal barrier sufficiently to induce a regulatory tolerant immune
response with transient inflammation ranging from none to mild. We were able to show a reg-
ulatory cellular response acutely, while the effects later in life were mainly characterized by
decreases in NK and NK T cells. An inflammatory challenge later in life, such as the oxazo-
lone-induced colitis model [48], or the use of a disease model with an early onset such as type
1 diabetes, would be useful to further evaluate the importance of both permanent and immedi-
ate effects of such early life manipulations.
Supporting information
S1 Fig. Projections of the qualitative and quantitative gut microbiota composition. Princi-
pal coordinate analysis (PCoA) plots of gut microbiota composition of mice during, and 1 and
25 days post treatment with 1.5% dextran sulfate sodium (DSS), 1g/L ampicillin and/or diet
containing 40.8 mg/kg lipopolysaccharides (LPS). Plots are based on unweighted (A, C, E) and
weighted (B, D, F) distance matrices calculated from 10 rarefied (10,000 reads) OTU tables
showing clear separation between groups. DSS+Amp and DSS+Amp+LPS treated mice on day
3 and 1 post-treatment were excluded due to the low DNA concentration in the isolates, con-
firming depletion of bacteria. As no qualitative or quantitative differences in bacterial compo-
sition were found between DSS+Amp mice and DSS+Amp+LPS on day 25 post-treatment,
these groups were combined for this time point. P-values of similarity (ANOSIM) between
treatment groups: Control vs DSS day 3; r = 0.987, p = 0.010 (A) and r = 0.850, p = 0.011 (B).
Control vs DSS day 1 pt.; r = 0.989, p = 0.003 (C) and r = 1.000, p = 0.006 (D). Day 25 pt: Con-
trol vs DSS; r = 0.518, p = 0.003 (E) and r = 0.324, p = 0.007 (F); Control vs Amp. groups;
r = 0.658, p = 0.001 (E) and ns (F).
(TIF)
S2 Fig. Study design. From arrival to treatment in week five, all mice were fed a standard diet.
During week five, one group was treated with 1.5% dextran sulfate sodium (DSS) in the drink-
ing water. Two groups received ampicillin (1g/L) in the drinking water from arrival and were
then co-treated during week five with either DSS, or with DSS and diet containing added lipo-
polysaccharide (LPS) (40.8 mg/kg LPS). The other treatment groups received corresponding
control diet. After one week of treatment all groups received standard diet and tap water. Mice
were killed on day 3 and 5 during treatment and on day 1, 7, and 25 post-treatment. From
these time points samples of blood, feces, liver, ileum and colon were taken. On day 3 during
treatment and on day 25 pt., the spleen and mesenteric lymph nodes were sampled (= FACS).
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For histology, samples of ileum and colon were preserved on day 3 during treatment, and on
day 1 and 25 pt. Samples from day 3 of treatment and from day 1 and 25 pt. were analyzed
(= S). P-values of similarity (ANOSIM) within groups over time (day 3-day 1 pt/day 1 pt-day
25 pt): Control unweighted = ns, weighted = p<, DSS unweighted = p</, weighted =
ns/p< (exact values not shown).
(TIF)
S1 File. DSS load, body weight, food and water intake. Data of mice during, and 1 and 25
days post treatment with 1.5% dextran sulfate sodium (DSS), 1g/L ampicillin and/or diet con-
taining 40.8 mg/kg lipopolysaccharides (LPS). Figure A. Average DSS load (mg/g BW, calcu-
lated from cage level water intake per mouse in cage) in the different treatment groups during
treatment, in week 5 (day 32–39). Ampicillin in the water increased the water intake, and
thereby DSS load in groups co-treated with ampicillin. Figures B+C. Food and water intake
divided in periods. Animals were treated from day 32–39. Day 21–28: First week of acclimati-
zation (ampicillin-treated groups were acclimatized to ampicillin water from arrival). Day 36–
49: From day 5 of treatment to 10 days post-treatment. Day 36–63: From day 5 of treatment to
day 25 post-treatment. Significantly increased water intake in groups receiving ampicillin (B),
and food intake was significantly increased in the first week of acclimatization (C). Figure D.
Overview curves of overall cumulative weight gain, water and food intake. Food and water
intake was measured on cage level and divided with the number of animals per cage. The mice
were weighed individually, but for these graphs the average weight of the animals in one cage
was used to calculate the average intake per mouse. Control and DSS show similar patterns
characterized by decrease in food intake, rise in water intake after treatment period (shaded
area). DSS+Amp and DSS+Amp+LPS had lower water and food intake during treatment com-
pared to control and DSS animals, with changes continuing in the period following treatment
cessation, where the mice consumed less food and lost weight, and elicited increased water
intake.
(PDF)
S1 Table. P-values for mRNA transcripts with <2 or >2 fold change.
(DOCX)
S2 Table. Analysis of variance of gut microbiota.
(DOCX)
S3 Table. RNA Integrity.
(DOCX)
S4 Table. Primers.
(DOCX)
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